Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Psychological resilience plays an important role in managing psoriasis symptoms and enhancing patient well-being, study ...

Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) announced its earnings results on Friday. The specialty pharmaceutical ...

The Montair LC tablet is an antiallergic tablet that relieves sneezing, itching, watery eyes, stuffy nose, and runny nose ...

That uncomfortable urge to scratch your palms might be more than just an annoyance. While some dismiss itchy palms as merely ...

ASN-008 is under clinical development by Formation Bio and currently in Phase II for Pruritus. According to GlobalData, Phase II drugs for Pruritus have a 50% phase transition success rate (PTSR) ...

Stock analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell ...

A Leeds woman who failed to get veterinary treatment for her dog who suffered from serious skin issues has been banned from ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...